![](/img/cover-not-exists.png)
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study
DeAngelo, Daniel J., Stock, Wendy, Stein, Anthony S., Shustov, Andrei, Liedtke, Michaela, Schiffer, Charles A., Vandendries, Erik, Liau, Katherine, Ananthakrishnan, Revathi, Boni, Joseph, Laird, A. DoVolume:
1
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2016001925
Date:
June, 2017
File:
PDF, 3.67 MB
2017